
|Videos|July 17, 2019
Advances in Metastatic Castration-Sensitive Prostate Cancer
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Subcutaneous Daratumumab for Smoldering Multiple Myeloma
2
Sacituzumab Govitecan Misses PFS in First-Line HR+/HER2– Metastatic Breast Cancer
3
FDA Grants Orphan Drug Status to Novel CD33-Directed Immunotherapy for AML
4
Lurbinectedin and Tarlatamab in ES-SCLC
5






































